Single 10 mg intravenous dose of abciximab, an antiplatelet drug used to prevent clotting during heart procedures

This code represents the administration of abciximab, a glycoprotein IIb/IIIa inhibitor, in a 10 mg dosage. Abciximab is an antiplatelet medication used to prevent blood clots, primarily in patients undergoing percutaneous coronary intervention (PCI). It works by blocking the aggregation of platelets, thereby reducing the risk of ischemic complications.

This code is used when abciximab is administered intravenously, typically as an adjunct to PCI for the prevention of acute cardiac ischemic events. It is also indicated for patients with unstable angina or non-Q-wave myocardial infarction who are scheduled for PCI. Documentation should clearly state the drug administered, the dosage (10 mg), and the route of administration.

• Ensure the documentation specifies the exact dosage of 10 mg; other dosages would require a different code or unlisted drug code.
• This code represents the drug itself, not the administration service. The administration service should be coded separately using appropriate CPT codes (e.g., for intravenous infusion).
• Verify medical necessity for the use of abciximab in conjunction with the patient's diagnosis and the procedure performed.